| Drug Class | Examples | Safety | Evidence | |------------|----------|--------|----------| | | Budesonide (Pregnancy Cat B), Fluticasone (Cat C, but widely used) | Preferred pharmacologic – minimal systemic absorption | RCTs show safety; budesonide has most pregnancy data. | | Intranasal antihistamines | Azelastine (Cat C) | Second-line | Limited data; systemic absorption low. | | Oral antihistamines (non-sedating) | Loratadine, Cetirizine (Cat B) | Reasonable for rhinorrhea/sneezing | No increased malformations in large cohort studies. | | Intranasal cromolyn sodium | Cromolyn (Cat B) | Safe but less effective | Very low absorption. | | Oral decongestants | Pseudoephedrine (Cat C) | Caution – Avoid in first trimester. Contraindicated with hypertension/pre-eclampsia. | Possible small risk of gastroschisis (first trimester). Use only short-term after 1st tri. | | Topical decongestants | Oxymetazoline (Cat C) | Avoid prolonged use (>3 days) due to rhinitis medicamentosa. | Minimal systemic absorption, but safety data sparse. |
Your information will be used to send you regular news updates from The Exponential Roadmap Initiative. We will only send you relevant information, and will never sell your information to any third parties. You have the absolute right to unsubscribe at any time. View our Privacy Policy.